Basics Fulgent Genetics, Inc. Fulgent Genetics Inc is a technology company offering genetic testing to provide physicians with clinically actionable diagnostic information used to improve the overall quality of patient care. IPO Date: September 29, 2016 Sector: Healthcare Industry: Medical Diagnostics and Research Market Cap: $550.12M Activated in VL: True Average Daily Range Avg Daily Range: $0.92 | 2.94% Avg Daily Range (30 D): $0.24 | 1.23% Avg Daily Range (90 D): $0.34 | 1.78% Institutional Daily Volume Avg Daily Volume: .3M Avg Daily Volume (30 D): .17M Avg Daily Volume (90 D): .27M Trade Size Avg Trade Size (Sh.): 63 Avg Trade Size (Sh.) (30 D): 43 Avg Trade Size (Sh.) (90 D): 46 Institutional Trades Total Inst.Trades: 1,715 Avg Inst. Trade: $1.85M Avg Inst. Trade (30 D): $.88M Avg Inst. Trade (90 D): $1.48M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.98M Avg Closing Trade (30 D): $.88M Avg Closing Trade (90 D): $1.57M Avg Closing Volume: 44.65K     News Jul 15, 2025 @ 11:41 PM Bragar Eagel & Squire, P.C. Is Investigating GoHea... Source: Bragar Eagel & Squire, P.C. Jul 1, 2025 @ 1:00 AM Bragar Eagel & Squire, P.C. Is Investigating GoHea... Source: Bragar Eagel & Squire, P.C. Jun 23, 2025 @ 4:53 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: N/A Jun 10, 2025 @ 1:00 AM Bragar Eagel & Squire, P.C. Is Investigating Semle... Source: N/A Jun 3, 2025 @ 1:00 AM Bragar Eagel & Squire, P.C. Is Investigating EchoS... Source: Bragar Eagel & Squire, P.C. Financials   TTM Q1 2025 Q4 2024 Basic EPS Diluted EPS Revenue $ 292.45M $ 73.46M $ 76.21M Gross Profit $ 113.46M $ 28.35M $ 31.85M Net Income / Loss $ -41.87M $ -11.9M $ -6.19M Operating Income / Loss $ -71.92M $ -19.8M $ -16.14M Cost of Revenue $ 178.99M $ 45.12M $ 44.37M Net Cash Flow $ 12.74M $ 12.14M $ -2.9M PE Ratio